Inhibiting estrogen responses in breast cancer cells using a fusion protein encoding estrogen receptor-α and the transcriptional repressor PLZF

Journal article

Peer reviewed

L Buluwela, J Pike, O Schwickerath, F Phoenix, R Hill, E Aboagye, S Shousha, J Waxman, N. R Lemoine, A Zelent, …

Gene therapy, Vol.12(5), pp.452-460

01/03/2005

PMID: 15647773

Abstract

Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy

Applied cell therapy and gene therapy

Biological and medical sciences

Biotechnology

Fundamental and applied biological sciences. Psychology

Gene therapy

Health. Pharmaceutical industry

Industrial applications and implications. Economical aspects

Medical sciences

Molecular and cellular biology

Molecular genetics

Transcription. Transcription factor. Splicing. Rna processing

Transfusions. Complications. Transfusion reactions. Cell and gene therapy

1 Record Views

Title: Inhibiting estrogen responses in breast cancer cells using a fusion protein encoding estrogen receptor-α and the transcriptional repressor PLZF
Creators - without role: L Buluwela - Imperial College London
J Pike - Imperial College London
O Schwickerath - Imperial College London
F Phoenix - Imperial College London
R Hill - Imperial College London
E Aboagye - Imperial College London
S Shousha - Queen Mary University of London
J Waxman - Imperial College London
N. R Lemoine - Imperial College London
A Zelent - Blood Cancer UK
R. C Coombes - Imperial College London
S Ali - Imperial College London
D Mazhar - Imperial College London
T Kamalati - Imperial College London
S. M Hart - Imperial College London
R AL-JEHANI - Imperial College London
H Yahaya - Imperial College London
N Patel - Imperial College London
N Sarwarl - Imperial College London
D. A Heathcote - Imperial College London
Publication Details: Gene therapy, Vol.12(5), pp.452-460
Publisher: Nature Publishing Group
Identifiers: 9937451108331
Academic Unit: King Abdulaziz University
Language: English
Resource Type: Journal article